Ceftaroline-associated Encephalopathy in Patients With Severe Renal Impairment.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 31504321.
- Also identified by DOI 10.1093/cid/ciz857 and PMC identifier 7156771.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Encephalopathy complicates beta-lactam therapy, particularly with impaired renal function, though no studies have reported ceftaroline-associated encephalopathy. Among 28 patients with estimated glomerular filtration rates <30 mL/min who received ≥5 days of ceftaroline, 3 developed encephalopathy. Ceftaroline, when dosed supra-therapeutically for serious infections, may be a cause of antibiotic-associated encephalopathy.
Medical subject headings
- Brain Diseases
- Renal Insufficiency